Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Although it has not yet reached zero, the likelihood of mother-to-child transmission fell below 1%.
The approval makes this the first single-pill regimen containing dolutegravir available in a water-dispersible formulation.
As sexually transmitted infections surge nationwide, a California law—the first of its kind—requires health insurance to cover home tests.
A high-quality trial should improve access to dolutegravir for children worldwide.
The Food and Drug Administration approved the single-pill treatment for children weighing at least 30 pounds.
The National Institutes of Health awarded grants for HIV cure research to these 10 organizations. One focuses on pediatric populations.
The federal HIV funding goes to 31 local housing programs and seven global data collection centers.
New guidelines from the Department of Health and Human Services went into effect immediately.
Globally, a child contracts HIV every 100 seconds. A new, affordable treatment is available, but the COVID-19 pandemic hinders access.
Here are the researchers who will lead the four networks of HIV trials and what each network will focus on.
Charles Lyons, president and CEO of the Elizabeth Glaser Pediatric AIDS Foundation, urges us to learn from HIV.
Young long-term survivors continue to face challenges.
Previously, kids weighing 44 to 88 pounds had to take lower doses—which are less available worldwide—and do so more than once a day.
This is according to a small study that analyzed the difference in rates of viral suppression among children of various ages.
The agency has also lowered the weight threshold for film-coated tablets of the integrase inhibitor.
The International AIDS Conference takes place July 6 to 10 in San Francisco and Oakland.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.